Variables median (IQR) | Patients with an acute episode of anaphylaxis (n = 49)a | Healthy subjects (n = 28)b | P-value | |||
---|---|---|---|---|---|---|
Acute sampling | Convalescent sampling | Acute vs. convalescent | Acute vs. healthy subjects | Convalescent vs. healthy subjects | ||
Serum chemokines (pg/ml) | ||||||
 CCL2/MCP-1 | 514 (561) | 284 (128) | 279 (147) | < 0.0001 | < 0.0001 | 0.9726 |
 CCL7/MCP-3 | 8.9 (2.9) | 8.5 (2.1) | 8.1 (1.4) | 0.7549 | 0.1636 | 0.1038 |
 CCL8/MCP-2 | 73 (56) | 69 (35) | 70 (19) | 0.1579 | 0.1425 | 0.4226 |
 CCL13/MCP-4 | 113 (81) | 104 (88) | 123 (103) | 0.9032 | 0.3367 | 0.7648 |
 CCL11/Eotaxin | 200 (174) | 211 (174) | 160 (60) | 0.2710 | 0.1641 | 0.0555 |
 CCL24/Eotaxin-2 | 1124 (1377) | 946 (1036) | 1159 (1561) | 0.0940 | 0.8665 | 0.5919 |
 CCL26/Eotaxin-3 | 1903 (88) | 1898 (181) | 1877 (155) | 0.0412 | 0.1746 | 0.4640 |
 CCL5/Rantes | 40,907 (34,588) | 41,795 (27,011) | 46,993 (33,574) | 0.6669 | 0.7485 | 0.9659 |
 CCL17/TARC | 342 (194) | 303 (203) | 344 (180) | 0.0148 | 0.7093 | 0.1931 |
 CCL21/SLC | 1179 (1193) | 1099 (645) | 938 (417) | 0.2206 | 0.3376 | 0.4175 |
 CCL22/MDC | 666 (321) | 717 (251) | 766 (260) | 0.7045 | 0.8014 | 0.5408 |
Serum tryptase | ||||||
 µg/l | 12.9 (10.6) | 5.3 (2.0) | 3.3 (2.0) | < 0.0001 | < 0.0001 | 0.0005 |
 > 11.4 µg/l, n (%) | 18 (60) | 1 (3.3) | 0 (0) | < 0.0001 | < 0.0001 | 1 |
Absolute cell count (cells/µl) | ||||||
 Basophils | 5.0 (7.3) | 19.1 (10.9) | – | < 0.0001 | – | – |
 Monocytes | 396 (163) | 441 (108) | – | 0.8417 | – | – |
 Lymphocytes | 1378 (1219) | 1461 (470) | – | 0.3904 | – | – |
 PMNs | 3881 (2873) | 2875 (1144) | – | 0.0388 | – | – |
Gene expression in whole blood (fold change) | ||||||
 FCER1A | 0.11 (0.24) | 0.40 (0.64) | – | 0.0002 | – | – |
 CPA3 | 0.22 (0.51) | 0.72 (1.16) | – | 0.0002 | – | – |
 HDC | 0.11 (0.30) | 0.38 (0.57) | – | 0.0018 | – | – |
Serum of patients used for in vitro migration assays | ||||||
 Tryptase (µg/l) | 22.6 (16.5) | 6.4 (6.2) | 4.3 (5.8) | 0.0002 | 0.0003 | 0.5358 |
 > 11.4 µg/l, n (%) | 8 (100) | 0 (0) | 0 (0) | 0.0002 | 0.0002 | 1 |
 CCL2 (pg/ml) | 1964 (1114) | 278 (175) | 302 (76) | 0.0002 | 0.0003 | 0.3969 |
Basophils of healthy donors used for the in vitro migration assays | ||||||
 Absolute count (cells/µl) | – | – | 18.3 (6.3) | – | – | – |
 CCR2 expression MFI | – | – | 353 (422) | – | – | – |
 % CCR2 + basophils | – | – | 94 (27) | – | – | – |